Stem Cell Cancer And Regenerative Medicine Research Inc
- Assets
- $559.0k
- Revenue
- $14.5k
- Investments
- $0.0
- Employees
- 0
- Location
- Boynton Beach, FL
- Founding
- 08/2007
- Data as of
- 12/2023
- EIN
- 51-0629988
Organization Overview
Stem Cell Cancer And Regenerative Medicine Research Inc is located in Boynton Beach, FL. The organization was established in 2007. According to its NTEE Classification (H90) the organization is classified as: Medical Disciplines Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Stem Cell Cancer And Regenerative Medicine Research Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Stem Cell Cancer And Regenerative Medicine Research Inc generated $14.5k in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 2.1% each year. All expenses for the organization totaled $36.6k during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE ORGANIZATION IS TO BE OPERATED FOR SCIENTIFIC AND EDUCATIONAL PURPOSES TO CONDUCT RESEARCH TO UNCOVER THE MOLECULAR BASIS OF CANCER AND DEGENERATIVE DISEASE WITH THE EMPHASIS ON CANCER INCLUDING MULTIPLE MYELOMA AND OTHER CHRONIC DISEASES INCLUDING FRAILTY.
Describe the Organization's Program Activity:
Part 3 - Line 4a
IN MAY 2008 THE ORGANIZATION STARTED A COLLABORATION WITH SCIENTISTS AT WAKE FOREST UNIVERSITY WHO HAVE DEVELOPED A PROTOCOL FOR USING GRANULOCYTES FOR TREATING SOLID TUMRORS. THE PROTOCOL WAS MODIFIED FOR IMPLEMENTATION AND INVESTIGATIONAL NEW DRUG APPROVAL WAS OBTAINED IN OCTOBER 2008 FOR A PHASE I/II CLINICAL TRIAL FOR 29 PATIENTS. WESTERN INSTITUTIONAL REVIEW BOARD APPROVAL WAS OBTAINED IN NOVEMBER 2008. THROUGH 2023, 17 PATIENTS HAVE BEEN TREATED AND 260 DONORS HAVE BEEN EVALUATED.
YOUNG BLOOD CLINICAL STUDY UNDER FOOD AND DRUG ADMINISTRATION APPROVAL EVALUATING THE SAFETY AND EFFICACY OF FRESH FROZEN PLASMA (GMFFP) FROM YOUNG HEALTHY DONORS AGES 18 TO 35, WHO HAVE GRANULOCYTE - COLONY STIMULATING FACTOR (G-CSF) TO AMELIORATE FRAILTY AND ENHANCE THE IMMUNE RISK PROFILE IN OLDER INDIVIDUALS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Susan Maharaj Director | Trustee | 1 | $0 |
Daniel Mangru Director | Trustee | 1 | $0 |
Dipnarine Maharaj MD President, D | OfficerTrustee | 6 | $0 |
Jacqueline Gouvea MD Secretary, T | OfficerTrustee | 4 | $0 |
Claudia Oliveira Director | Trustee | 1 | $0 |
Richard Simon Director | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $10,194 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $10,194 |
| Total Program Service Revenue | $0 |
| Investment income | $4,320 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $14,514 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $25,000 |
| Advertising and promotion | $0 |
| Office expenses | $4,597 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $2,500 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $0 |
| All other expenses | $0 |
| Total functional expenses | $36,558 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $970 |
| Savings and temporary cash investments | $542,943 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $15,105 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $559,018 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $4,270 |
| Total liabilities | $4,270 |
| Net assets without donor restrictions | $0 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $554,748 |
| Total liabilities and net assets/fund balances | $559,018 |